Metraipolis › archive › dc_cbc9964f875d
Prostaglandin E1 in ischemic retinal diseases: mechanisms, evidence, and clinical perspectives — Europe PMC PMID:41737389
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41737389
- DOI
- 10.3389/fmed.2026.1749690
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T00:43:27.418Z
- SHA-256 of the archived text
64426b39ad0eddbd0ffa7c3b0cefa80bacbdfc3a18e400afcab6b09ba925ced0- Stable URL of this page
https://metraipolis.com/documento/dc_cbc9964f875d
How to cite
Prostaglandin E1 in ischemic retinal diseases: mechanisms, evidence, and clinical perspectives — Europe PMC PMID:41737389 — Europe PMC (en), https://europepmc.org/article/MED/41737389 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cbc9964f875d (Metraipolis archive dc_cbc9964f875d, sha256 64426b39ad0eddbd0ffa7c3b0cefa80bacbdfc3a18e400afcab6b09ba925ced0)
BibTeX
@misc{dccbc9964f875d,
title = {Prostaglandin E1 in ischemic retinal diseases: mechanisms, evidence, and clinical perspectives — Europe PMC PMID:41737389},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41737389},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cbc9964f875d; sha256 64426b39ad0eddbd0ffa7c3b0cefa80bacbdfc3a18e400afcab6b09ba925ced0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41737389. Agents can read the archived copy with the MCP tool read_document.